Pomegranate Menopausal Symptoms Randomized Trial: What the Evidence Says

Quick Answer

Pomegranate Menopausal Symptoms Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• They not only have a significant impact on quality of life and social well-being but, if left untreated or undertreated, they can increase the risk of developing various complications, including organ dysfunction and genitourinary cancers. [Piragine Eugenia (2026); evidence level 1]
• Among these, polyphenols, which can be found in plants but also in microbial sources such as algae, have been extensively studied in both preclinical and clinical settings. [Piragine Eugenia (2026); evidence level 1]
• Menopause, the permanent cessation of menstruation due to declining estrogen and progesterone levels, typically occurs between ages 50 and 52 and is associated with physical and psychological symptoms that can impair health-related quality of life (QoL). [Jarrín-Orozco María P. (2025); evidence level 2]
• Adding to this complexity, up to 12 possible combinations of these metabotypes, termed metabotype clusters (MCs), can occur when consuming isoflavones, resveratrol, and ellagic acid, as a result of the combination of the individual metabotypes (e.g., UMA+EP+LP, UMB+ENP+LP, etc.). [Jarrín-Orozco María P. (2025); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. There is trial evidence in the current set, but population and intervention details still matter. For pomegranate menopausal symptoms randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Piragine Eugenia (2026). Potential Efficacy of Polyphenols and Isothiocyanates in the Management of Genitourinary Diseases: A Systematic Review of Preclinical and Clinical Studies. DOI: 10.3390/ijms27041660. PMCID: PMC12940174. PMID: 41751796. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12940174/
• Jarrín-Orozco María P. (2025). Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial. DOI: 10.3390/nu17223572. PMCID: PMC12655133. PMID: 41305622. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12655133/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.